Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements
Search Results:
1-15 of 54230 results
Bristol-Myers Squibb, Janssen collaborate on lung cancer treatment
By PBR Staff Writer
Bristol-Myers Squibb (BMS) and Janssen Biotech have signed a clinical study collaboration agreement to evaluate the combination of two immuno-oncology compounds in patients with non-small cell lung cancer (NSCLC).
Contract Research & Services > Contract Research > News
Hybrigenics Services Introduces Hybribody
The new All-In-One service for the selection and validation of antibodies derived from a fully synthetic humanized VHH antibody library.
Contract Research & Services > Contract Research > Products
Merck's Ebola Zaire vaccine gets accelerated review designations in US and Europe
By PBR Staff Writer
Merck’s experimental Ebola Zaire vaccine, V920, has received accelerated review status in the US and European Union.
Production & Manufacturing > Process & Production > News
Tricida raises $55m for kidney disease treatment
By PBR Staff Writer
Clinical stage, biopharmaceutical firm Tricida has raised $55m in funding for late-stage trials of its lead candidate, TRC101, in patients with kidney disease.
Drug Research > Drug Discovery & Development > News
FDA lifts clinical hold on CGF166
GenVec, a clinical-stage gene delivery company, was notified by its collaborator, Novartis, that the Food and Drug Administration (FDA) has lifted the clinical hold on the Phase 1/2 clinical trial of CGF166 in patients with severe to profound hearing loss.
Regulatory Affairs > News
Just Biotherapeutics secures $14M series A2 funding
Just Biotherapeutics, an organization dedicated to expanding global access to important protein therapeutics, announced the closing of a $14M Series A2 financing round.
Production & Manufacturing > Manufacturing > News
Eiger doses first patient in phase 2 study of Ubenimex in secondary lymphedema
Eiger BioPharmaceuticals announced that the first patient in the Phase 2 ULTRA study was dosed at Stanford University.
Contract Research & Services > Clinical Trials > News
Vtesse secures $17m in additional Series A funding
Vtesse, a company committed to developing drugs that will benefit patients with extremely rare, life-threatening diseases, has secured $17m in additional Series A funding in support of its global, pivotal clinical trial of VTS-270 for Niemann-Pick Type C1 disease (“NPC”).
Drug Research > Drug Discovery & Development > News
AbbVie, Bristol-Myers Squibb partner on combo treatment for lung cancer
By PBR Staff Writer
AbbVie and Bristol-Myers Squibb (BMS) are collaborating on a clinical trial combining both companies’ checkpoint inhibitors to treat relapsed extensive-stage small cell lung cancer (SCLC).
Contract Research & Services > Contract Research > News
Bruker Launches New BRAVO Handheld Raman Spectrometer
The new Bruker Raman Verification Optics (BRAVO) complements Bruker’s Raman product range. It features an innovative fluorescence mitigation, intuitive graphical user interface, and a superior guided work-flow, amongst other assets. Due to its unique optical design, BRAVO is the only handheld Raman spectrometer that is certified as a class 1M Laser product.
Automation > Laboratory Instrumentation > Press Releases
FDA raises concerns over manufacturing practice of Valeant’s new ophthalmic solution
By PBR Staff Writer
The US Food and Drug Administration has raised concerns over manufacturing practice of Valeant Pharmaceuticals International’s new eye drop.
Regulatory Affairs > News
European CHMP recommends Shire’s Onivyde to treat metastatic adenocarcinoma
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion for Shire’s Onivyde (irinotecan pegylated liposomal formulation) to treat metastatic adenocarcinoma.
Regulatory Affairs > News
European CHMP adopts positive opinion on Gilead’s Type II variation application for Truvada
By PBR Staff Writer
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Gilead Sciences' Type II variation application for Truvada for reducing the risk of sexually acquired HIV.
Regulatory Affairs > News
FDA Grants QIDP to Morphochem’s intravenous antibacterial to treat C. difficile infections
By PBR Staff Writer
Morphochem, a clinical-stage pharmaceutical company, announced that the US Food and Drug Administration (FDA) has designated Morphochem’s intravenous (IV) antibacterial product candidate MCB3837 as a Qualified Infectious Disease Product (QIDP) for the treatment of Clostridium difficile infection (CDI).
Hybrigenics Services - Protein Interactions Expert
Who else knows your protein better than you? Who else knows proteins interactions better than us?
Contract Research & Services > Contract Research > Suppliers

PBR Supplier Recommendations

Hybrigenics Services - Protein Interactions Expert
Who else knows your protein better than you? Who else knows proteins interactions better than us?... Contract Research & Services > Contract Research > Suppliers
SchuF Valves- Innovative, custom valve solutions for the pharmaceutical industry
The SchuF group, inventor of the bottom outlet valve, manufactures custom, flush-mounted valves that eliminate dead space in the reactor outlet nozzle. The main features and benefits of SchuF valves include the following;... Suppliers
Bruker Optics - Fourier Transform Infrared, Near Infrared and Raman Spectrometers
Bruker Optics is the leading manufacturer and worldwide supplier of fourier transform Infrared (FTIR), near infrared and raman spectrometers for a number of industries and applications, such as pharmaceutical and life sciences.... Automation > Laboratory Instrumentation > Suppliers
LABORATORIOS INIBSA - Pharmaceutical Contract Manufacturing Company
LABORATORIOS INIBSA is a pharmaceutical contract manufacturing company. We have more than 60 years' experience and belong to the INIBSA GROUP. INIBISA supplies products and services to Biotools, Inibsa Dental and Inibsa Hospital, as well as other pharmaceutical companies through our contract manufacturing division. From our facilities in Lliçà de Vall, 20km from Barcelona LABORATORIOS INIBSA currently supplies more than 50 countries worldwide.... Production & Manufacturing > Manufacturing > Suppliers
SHL Healthcare - Developer and Manufacturer for Equipment Solutions
SHL Healthcare develops and manufactures equipment solutions for home, hospital and long-term care use with a focus on patient comfort and functionality. Our broad range of products include medical slings, rehabilitation beds, pressure mattress systems, lifting equipment, medical soft goods and a variety of related accessories. ... Suppliers
See more

PBR White Paper Recommendations

Five Ways That the Mastersizer 3000 Saves you Money By Malvern Instruments
To earn its place in today’s busy analytical laboratories, an instrument must meet certain practical criteria, and stand-up to rigorous economic evaluation. For labs that need particle sizing, laser diffraction systems are typically the technology of choice; delivering accurate and reliable information for the broadest range of sample types. Here, we look at how the Mastersizer 3000, the market leading laboratory particle size analyzer from Malvern Instruments, can save you time, money and resources, and ultimately deliver a healthy return on investment.... White Papers Time to Spec up? Top Five Reasons to Replace a Viscometer with a Rheomete By Malvern Instruments
Is your viscometer approaching the end of its life? Are you starting to feel that your trial and error, ‘rheology-light’ approach to formulation is becoming dated? Or are there longstanding product performance issues that you’re failing to gain traction with, where you suspect rheology may hold the answer?... White Papers Biophysical Characterization of Epigenetic Protein Interactions By Malvern Instruments
Epigenetics is the study of heritable changes in gene expression caused by nongenetic mechanisms, without alterations in gene structure or DNA sequence. The epigenetic state of a cell evolves during the cellular differentiation and development of an organism, and epigenetic changes are linked to cellular reprogramming. Because epigenetic mechanisms may also be responsible for the integration of environmental responses at he cellular level, they potentially play an important role in the development of som diseases.... White Papers Overcoming and Quantifying 'Wall Slip' in Measurements from a Rotational Rheometer By Malvern Instruments
When making shear rheological measurements on structured liquids, in particular suspensions, emulsions or foams there is a high probability that the measurement may be affected by a phenomenon known as 'wall slip'. Wall slip generally results from a localdepletion of the dispersed phase near the geometry walls, effectively forming a lubrication layer at the surface. As a consequence bulk rheological properties are no longer being accurately measured leading to an underestimation of the true viscosity. A similar effect can be observed when measuring solid like materials where there is insufficient friction between the sample and the wall to support the applied stress.... White Papers Preformulation and Stability Studies of Biotherapeutics Using DSC By Malvern Instruments
The use of biotherapeutics, such as antibodies and other protein molecules, to treat diseases is a rapidly growing field in the pharmaceutical industry.Biotherapeutics are often required at high concentrations and multiple doses, hence a manufacturer must produce kilogram quantities or more of the protein drug. The manufacturing process for biotherapeutics involves protein expression in thousands of liters of bioreactor medium followed by a purification process using large-scale chromatography columns and filtration systems.... White Papers See more
1-15 of 54230 results